ADDITIONAL INFORMATION 21 21.2.6 STIPULATIONS THAT ALLOW DELAYING, The notification shall be repeated in the conditions stated above DEFERRING OR PREVENTING A CHANGE IN each time an additional fraction of 2.5% of the share capital or CONTROL OF THE COMPANY voting rights is crossed upward or downward. There are no provisions either in the Company’s bylaws or in In the event of failure to comply with the notification requirements any internal charter or internal rules that could have the effect described above, shares exceeding the fraction that should have of delaying, postponing or preventing a change of control of the been notified will be deprived of voting rights at shareholders’ Company. meetings if, at such meetings, the notification failure has been recorded and if one or more shareholders jointly holding at least 21.2.7 DECLARATION OF THRESHOLDS 2.5% of the share capital so request. Loss of voting rights shall be (ARTICLE 12 OF THE BYLAWS) applicable in all shareholders’ meetings that would be held up until In addition to the thresholds provided for by applicable laws and two years following proper notification. regulations, any natural person or legal entity who comes to hold or ceases to hold, acting alone or in concert within the meaning 21.2.8 PARTICULAR STIPULATIONS GOVERNING of Article L.233-10 of the French Commercia Code, directly orl MODIFICATIONS OF THE SHARE CAPITAL indirectly, a number of shares representing at least 2.5% of the As the bylaws do not provide any specific stipulations, the share share capital or voting rights, including beyond the reporting capital may be increased, decreased or amortized by any methods thresholds provided for by laws and regulations, must inform the or means authorized by law. Company of the total number of shares and voting rights of the Company that such person holds, by registered letter with return receipt requested sent to the Company’s registered office within four trading days after crossing such threshold(s). Such person shall also indicate the number of securities giving access to the capital and the voting right potentially attached thereto, as well as any other information provided for by law. 230– GENSIGHT BIOLOGICS – 2017 Registration Document